GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (MEX:OCGN) » Definitions » Ending Cash Position

Ocugen (MEX:OCGN) Ending Cash Position : MXN767.94 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ocugen Ending Cash Position?

Ocugen's Ending Cash Position for the quarter that ended in Sep. 2024 was MXN767.94 Mil.

Ocugen's quarterly Ending Cash Position declined from Mar. 2024 (MXN437.73 Mil) to Jun. 2024 (MXN293.10 Mil) but then increased from Jun. 2024 (MXN293.10 Mil) to Sep. 2024 (MXN767.94 Mil).

Ocugen's annual Ending Cash Position declined from Dec. 2021 (MXN1,951.07 Mil) to Dec. 2022 (MXN1,512.17 Mil) and declined from Dec. 2022 (MXN1,512.17 Mil) to Dec. 2023 (MXN669.84 Mil).

Ocugen Ending Cash Position Historical Data

The historical data trend for Ocugen's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Ending Cash Position Chart

Ocugen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.24 481.19 1,951.07 1,512.17 669.84

Ocugen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 931.51 669.84 437.73 293.10 767.94

Ocugen Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ocugen's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1316.574+-646.736
=669.84

Ocugen's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=315.024+452.917
=767.94

Ocugen Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ocugen's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocugen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (MEX:OCGN) » Definitions » Ending Cash Position
Comparable Companies
SGMO BDTX NYMXF KPTI ABEO ALDX RLMD HOWL MIRO GMDA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
OCGN:USA 2H51:Germany
Address
11 Great Valley Parkway, Malvern, PA, USA, 19355
Website
https://www.ocugen.com
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").